Key facts
- This page summarizes Antonio Migliarese's Form 4 filing for CytoDyn Inc. (CYDY).
- 12 reported transactions and 12 derivative rows are listed below.
- Accepted by SEC: 05 Jan 2024, 21:04.
Antonio Migliarese - 03 Jan 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2024, 21:04:57 UTC
- Prior SEC filing
- 30 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Antonio Migliarese
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Antonio Migliarese filed Form 4 for CytoDyn Inc. (CYDY) on 05 Jan 2024.
Change
- Previous filing in this sequence was filed on 30 Nov 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -50,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $1.03
- Footnotes
- F1, F2
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -50,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $1.10
- Footnotes
- F1, F2
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -100,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $5.57
- Footnotes
- F1, F2
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -50,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $5.54
- Footnotes
- F2, F3
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -1,000,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000,000
- Exercise price
- $1.32
- Footnotes
- F2, F4
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -630,222
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 630,222
- Exercise price
- $0.5800
- Footnotes
- F2, F5
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- Shares
- +50,000
- Change %
- Price
- Shares after
- 50,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $0.2100
- Footnotes
- F2
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- Shares
- +50,000
- Change %
- Price
- Shares after
- 50,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $0.2100
- Footnotes
- F2
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- Shares
- +100,000
- Change %
- Price
- Shares after
- 100,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.2100
- Footnotes
- F2
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- Shares
- +50,000
- Change %
- Price
- Shares after
- 50,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $0.2100
- Footnotes
- F2, F6
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- Shares
- +1,000,000
- Change %
- Price
- Shares after
- 1,000,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000,000
- Exercise price
- $0.2100
- Footnotes
- F2, F7
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- Shares
- +630,222
- Change %
- Price
- Shares after
- 630,222
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 630,222
- Exercise price
- $0.2100
- Footnotes
- F2, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
The option was fully vested and exercisable prior to January 3, 2024.
Footnote F2
The outstanding option was cancelled in exchange for a new option having a lower exercise price.
Footnote F3
Vesting was scheduled to occur in three equal annual installments beginning on February 17, 2022.
Footnote F4
Vesting was scheduled to occur in three equal annual installments beginning on August 6, 2022.
Footnote F5
25% of the award vested on January 24, 2023, with the balance scheduled to vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.
Footnote F6
33,300 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on February 17, 2024.
Footnote F7
666,000 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on August 6, 2024.
Footnote F8
301,975 shares were fully vested and exercisable on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through January 2026.